These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3989377)

  • 1. Human apolipoprotein A-I isoprotein metabolism: proapoA-I conversion to mature apoA-I.
    Bojanovski D; Gregg RE; Ghiselli G; Schaefer EJ; Light JA; Brewer HB
    J Lipid Res; 1985 Feb; 26(2):185-93. PubMed ID: 3989377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proapolipoprotein A-I conversion kinetics in vivo in human and in rat.
    Ghiselli G; Gotto AM; Tanenbaum S; Sherrill BC
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):874-8. PubMed ID: 3919384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo metabolism of proapolipoprotein A-I in Tangier disease.
    Bojanovski D; Gregg RE; Zech LA; Meng MS; Bishop C; Ronan R; Brewer HB
    J Clin Invest; 1987 Dec; 80(6):1742-7. PubMed ID: 3119665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of proapoa-I in rat lymph and plasma: metabolic conversion to "mature" apoA-I.
    Ghiselli G; Bradley WA; Gotto AM; Sherrill BC
    Biochem Biophys Res Commun; 1983 Oct; 116(2):704-11. PubMed ID: 6418165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human proapolipoprotein A-I: development of an antibody to the propeptide as a probe of apolipoprotein A-I biosynthesis and processing.
    Hospattankar AV; Fairwell T; Appella E; Meng M; Brewer HB
    Biochem Biophys Res Commun; 1987 Nov; 149(1):289-96. PubMed ID: 3120726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.
    Huang W; Matsunaga A; Li W; Han H; Hoang A; Kugi M; Koga T; Sviridov D; Fidge N; Sasaki J
    Atherosclerosis; 2001 Nov; 159(1):85-91. PubMed ID: 11689210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I.
    Batal R; Tremblay M; Krimbou L; Mamer O; Davignon J; Genest J; Cohn JS
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):655-64. PubMed ID: 9555873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
    Huang W; Sasaki J; Matsunaga A; Han H; Li W; Koga T; Kugi M; Ando S; Arakawa K
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):210-6. PubMed ID: 10634820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression.
    Sorci-Thomas MG; Parks JS; Kearns MW; Pate GN; Zhang C; Thomas MJ
    J Lipid Res; 1996 Mar; 37(3):673-83. PubMed ID: 8728328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human plasma proapoA-I: isolation and amino-terminal sequence.
    Brewer HB; Fairwell T; Kay L; Meng M; Ronan R; Law S; Light JA
    Biochem Biophys Res Commun; 1983 Jun; 113(2):626-32. PubMed ID: 6409108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metabolism of apolipoprotein A-IV in humans.
    Ghiselli G; Krishnan S; Beigel Y; Gotto AM
    J Lipid Res; 1986 Aug; 27(8):813-27. PubMed ID: 3095477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration that the enzyme that converts precursor of apolipoprotein A-I to apolipoprotein A-I is secreted by the hepatocarcinoma cell line Hep G2.
    Edelstein C; Kaiser M; Piras G; Scanu AM
    Arch Biochem Biophys; 1988 Nov; 267(1):23-30. PubMed ID: 2848450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.
    Rader DJ; Schäfer J; Lohse P; Verges B; Kindt M; Zech LA; Steinmetz A; Brewer HB
    J Clin Invest; 1993 Aug; 92(2):1009-17. PubMed ID: 8349786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High yield overexpression and characterization of human recombinant proapolipoprotein A-I.
    McGuire KA; Davidson WS; Jonas A
    J Lipid Res; 1996 Jul; 37(7):1519-28. PubMed ID: 8827524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human proapoA-ITangier: isolation of proapoA-ITangier and amino acid sequence of the propeptide.
    Brewer HB; Fairwell T; Meng M; Kay L; Ronan R
    Biochem Biophys Res Commun; 1983 Jun; 113(3):934-40. PubMed ID: 6409109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein.
    Sviridov D; Pyle LE; Jauhiainen M; Ehnholm C; Fidge NH
    J Lipid Res; 2000 Nov; 41(11):1872-82. PubMed ID: 11060357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptide.
    Barkia A; Martin C; Puchois P; Gesquiere JC; Cachera C; Tartar A; Fruchart JC
    J Lipid Res; 1988 Jan; 29(1):77-84. PubMed ID: 3282017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid binding properties of the Tangier apolipoprotein A-I and its isoproteins.
    Rosseneu M; Assmann G; Taveirne MJ; Schmitz G
    J Lipid Res; 1984 Feb; 25(2):111-20. PubMed ID: 6423754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I isoforms in human lymph: effect of fat absorption.
    Ghiselli G; Schaefer EJ; Light JA; Brewer HB
    J Lipid Res; 1983 Jun; 24(6):731-6. PubMed ID: 6411847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the propeptide of apolipoprotein A-I impairs exit of nascent apolipoprotein A-I from the endoplasmic reticulum.
    McLeod RS; Robbins C; Burns A; Yao Z; Pritchard PH
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):641-8. PubMed ID: 7945187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.